Lucas N. Alberca
Orcid: 0000-0002-2819-2046
According to our database1,
Lucas N. Alberca
authored at least 7 papers
between 2013 and 2023.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2023
A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity.
J. Comput. Aided Mol. Des., February, 2023
2022
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small Molecules.
J. Chem. Inf. Model., 2022
Tetracycline Derivatives Inhibit Plasmodial Cysteine Protease Falcipain-2 through Binding to a Distal Allosteric Site.
J. Chem. Inf. Model., 2022
2021
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study.
J. Chem. Inf. Model., 2021
2020
Application of target repositioning and in silico screening to exploit fatty acid binding proteins (FABPs) from Echinococcus multilocularis as possible drug targets.
J. Comput. Aided Mol. Des., 2020
2016
Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.
J. Comput. Aided Mol. Des., 2016
2013
Application of Computer-Aided Drug Repurposing in the Search of New Cruzipain Inhibitors: Discovery of Amiodarone and Bromocriptine Inhibitory Effects.
J. Chem. Inf. Model., 2013